Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment for Advanced Pancreatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchNot Yet RecruitingNCT07394205
What this trial is testing

Clinical Study of CBG131 CAR-T Cell Injection for the Treatment of CLDN18.2-Positive Advanced Gastric and Pancreatic Cancer

Who this might be right for
Advanced Gastric and Pancreatic Cancer
First Affiliated Hospital of Wenzhou Medical University 18
Testing effectiveness (Phase 2)Study completedNCT00002773
What this trial is testing

Vaccine Therapy, Chemotherapy, and GM-CSF in Treating Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
St. Vincent Medical Center - Los Angeles
Not applicableStudy completedNCT02282722
What this trial is testing

Improving Informed Consent for Palliative Chemotherapy

Who this might be right for
Metastatic Colorectal CancerMetastatic Pancreatic CancerUnresectable Pancreatic Cancer
Dana-Farber Cancer Institute 216
Early research (Phase 1)Study completedNCT02451553
What this trial is testing

Afatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmBile Duct CarcinomaRecurrent Malignant Solid Neoplasm+4 more
University of Washington 41
Early research (Phase 1)Study completedNCT01420874
What this trial is testing

Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer)

Who this might be right for
Colorectal CancerCancer of PancreasPancreatic Neoplasm+5 more
Barbara Ann Karmanos Cancer Institute 15
Testing effectiveness (Phase 2)Looking for participantsNCT06453486
What this trial is testing

High Dose Radiation Therapy for Locally Advanced Pancreatic Cancer That Responded to Initial Chemotherapy Treatment

Who this might be right for
Locally Advanced Pancreatic Adenocarcinoma
University Health Network, Toronto 43
Very early researchNot Yet RecruitingNCT06619886
What this trial is testing

TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor

Who this might be right for
Solid Tumor, AdultLung AdenocarcinomaPancreas Cancer+2 more
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 9
Testing effectiveness (Phase 2)UnknownNCT04803851
What this trial is testing

Anlotinib Plus Anti-PD-1 Antibody AK105 for Advanced Pancreatic Cancer

Who this might be right for
AnlotinibAnti-PD-1 AntibodyAdvanced Pancreatic Cancer
Peking Union Medical College Hospital 29
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07208539
What this trial is testing

AG Followed by FOLFIRINOX Both Combined With PD-L1 Antibodies as a Conversion Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer.

Who this might be right for
Pancreatic Cancer
Shanghai Zhongshan Hospital 77
Early research (Phase 1)Study completedNCT00836407
What this trial is testing

Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 30
Testing effectiveness (Phase 2)Study completedNCT00964171
What this trial is testing

Efavirenz as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Institut Bergonié 19
Not applicableStudy completedNCT02750657
What this trial is testing

Study of Changes and Characteristics of Genes in Patients With Pancreatic Cancer for Better Treatment Selection

Who this might be right for
Carcinoma, Pancreatic Ductal
University Health Network, Toronto 332
Not applicableStudy completedNCT00448838
What this trial is testing

Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Miami 42
Testing effectiveness (Phase 2)Looking for participantsNCT07306286
What this trial is testing

Cryoablation Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy

Who this might be right for
Pancreatic Adenocarcinoma Locally Advanced
Ruijin Hospital 20
Testing effectiveness (Phase 2)Study completedNCT02620865
What this trial is testing

BATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic AdenocarcinomaRecurrent Pancreatic CarcinomaStage III Pancreatic Cancer+1 more
Barbara Ann Karmanos Cancer Institute 2
Not applicableUnknownNCT03882866
What this trial is testing

Iodine-125 Seed Implantation Therapy for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Ruijin Hospital 220
Testing effectiveness (Phase 2)Looking for participantsNCT05431270
What this trial is testing

Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)

Who this might be right for
Non Small Cell Lung CancerPancreatic Ductal Adenocarcinoma
Phanes Therapeutics 40
Not applicableLooking for participantsNCT04622423
What this trial is testing

Advanced Therapies for Liver Metastases

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Colorectal Cancer (CRC)Liver Metastasis+1 more
IRCCS San Raffaele 625
Early research (Phase 1)Study completedNCT03884556
What this trial is testing

TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers

Who this might be right for
Solid TumorLymphoma
Trishula Therapeutics, Inc. 56
Testing effectiveness (Phase 2)Study completedNCT04953962
What this trial is testing

Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Stage IV
CanBas Co. Ltd. 36
Next Page